Association of 18F‐flortaucipir PET with tau neuropathology in AD and other neurodegenerative disorders

Background Tau‐PET with [18F]Flortaucipir is FDA‐approved for the identification of AD tau neuropathology in the differential diagnosis of patients with cognitive impairment. However, its performance in detecting early AD stages requires further assessment. We aimed to i) examine the relationships b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer's & dementia 2025-01, Vol.20 (Suppl 2), p.n/a
Hauptverfasser: Vrillon, Agathe, Mejía‐Perez, Jhony Alejandro, Spina, Salvatore, Schonhaut, Daniel R., Yballa, Claire, soleimani‐meigooni, David N., Boxer, Adam L., Dage, Jeffrey L., Rojas, Julio C., VandeVrede, Lawren, Lago, Argentina Lario, Jagust, William J., Miller, Bruce L., Rosen, Howard J., Seeley, William W., Grinberg, Lea T., Rabinovici, Gil D., Joie, Renaud La
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!